GIPM
GNMK

G2 Investment Partners Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

G2 Investment Partners Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-396,400
Closed -$9.47M – 111
2021
Q1 		$9.47M Sell
396,400
-361,837
-48% -$6.73M 1.51% 28
2020
Q4 		$11.1M Sell
758,237
-62,824
-8% -$833K 2.03% 20
2020
Q3 		$11.7M Buy
821,061
+106,461
+15% +$1.63M 2.81% 8
2020
Q2 		$10.5M Buy
+714,600
New +$7.26M 2.49% 12

G2 Investment Partners Management's GNMK Position: Q2 2021 in Review

G2 Investment Partners Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 396,400 shares — an estimated $9.47M sold.

G2 Investment Partners Management first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $11.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • G2 Investment Partners Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • G2 Investment Partners Management sold 396,400 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $9.47M.
  • G2 Investment Partners Management first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
  • G2 Investment Partners Management's GenMark Diagnostics, Inc position peaked at $11.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on G2 Investment Partners Management's 13F filing for Q2 2021, filed 16 Aug 2021.